Regulatory Update: Ice and Vibration Stimuli Assessed for Upper Extremity Dysfunction in Completed Trial

Publication date context: February 13, 2026. A completed clinical trial examines whether ice and vibration stimuli influence muscle activation, hand grip strength, reaction time, and hand function in individuals with upper extremity dysfunction. The record identifies Lokman Hekim University as sponsor and lists the clinical trial identifier NCT07407114. The source text does not present outcomes. This article reframes the fragment as a regulatory news item for medical device professionals who monitor device related evidence and safety signals.

What stimuli were evaluated and why?

The source text lists two stimuli used in the trial: ice and vibration. These modalities are common study topics in neuromuscular performance and sensory feedback research. In a device regulated context they may require careful safety and performance documentation. The current record does not publish outcome data, only the existence of the interventions.

What were the study conditions and interventions?

The trial identifies a condition labeled upper extremity dysfunction. The interventions listed are ice and vibration. The sponsor is Lokman Hekim University. The status indicates completed, with the clinical trial identifier NCT07407114. The source text does not provide numerical results or a full protocol beyond these items.

What outcomes were considered for muscle activation and hand function?

Reported outcomes include measures of muscle activation, hand grip strength, reaction time, and overall hand function. The record does not include numerical findings. Users should view the primary registry for results when they become available.

What are the regulatory implications for devices using similar stimuli?

From a regulatory perspective the record highlights modalities that might be used in upper limb devices. Any claims about performance or safety would require documentation aligned with medical device regulation. In the European market the MDR Annex XIV items call for declared intended use, performance claims, and safety evaluations. The article notes the absence of published results in the cited record, which means no conclusions are drawn about efficacy or safety from this source alone.

What is known about the study design and status?

The record shows a completed study as of the time stamp 2026 02 13. It lists the condition and the two interventions, with no further design details provided in the source text. Readers should consult the registry for trial design specifics and documented results.

FAQ

  1. 1. What is the purpose of this trial? The trial aims to evaluate how ice and vibration stimuli affect outcomes in upper extremity dysfunction.
  2. 2. Which stimuli are involved? Ice and vibration.
  3. 3. Who sponsors this trial? Lokman Hekim University.
  4. 4. Where can results be found? The primary registry NCT07407114; The source does not include results.
  5. 5. Does this imply a new device claim? It signals potential areas for device development but no claims are made in the extract.

Conclusion

In summary the record confirms the existence of a completed trial testing ice and vibration for upper extremity dysfunction. It does not present results within the extract. For device developers and regulators this signals a need to monitor registry updates for efficacy and safety data and to align any claims with regulatory requirements and safety standards.

Disclaimer

This information is intended for professionals. It is not legal advice. It should not be used as a substitute for regulatory counsel or formal guidance from authorities.

For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07407114?term=medical+device
Scroll to Top